Variables | ESRD (n = 20) | |||
---|---|---|---|---|
Non-diabetic (n = 14) | Diabetic (n = 6) | |||
Age (years) | 58.07 ± 12.85 | 58.17 ± 7.17 | ||
Sex (male/female) | 11/3 | 6/0 | ||
BMI (kg/m2) | 23.54 ± 2.90 | 29.76 ± 6.42 | ||
Antihypertensive agents | ||||
 ARB/ACE inhibitor | 6 (42.86 %) | 6 (100 %) | ||
 Ca channel blocker | 12 (85.71 %) | 4 (66.67 %) | ||
Hypoglycemic drugs | ||||
 Insulin |  | 4 (66.67 %) | ||
 Dpp-4 inhibitor |  | 1 (16.67 %) | ||
 Sulfonylurea |  | 0 (0 %) | ||
 α-GI |  | 2 (33.33 %) | ||
Biochemical parameters | Before PD | After PD | Before PD | After PD |
 Total protein (mg/dL) | 6.02 ± 0.98 | 6.39 ± 0.71* | 5.60 ± 0.86 | 6.17 ± 0.50* |
 Albumin (g/dL) | 3.38 ± 0.75 | 3.43 ± 0.59 | 2.93 ± 0.62 | 3.15 ± 0.56 |
 BUN (mg/dL) | 71.64 ± 16.70 | 53.08 ± 11.64** | 67.47 ± 20.76 | 48.10 ± 12.62** |
 Creatinine (mg/dL) | 10.90 ± 3.93 | 9.96 ± 3.46* | 10.50 ± 1.85 | 10.08 ± 2.21 |
 e-GFR (mL/min/1.73 m2) | 4.89 ± 1.91 |  | 4.84 ± 1.39 |  |
 HbA1c (%) | 5.33 ± 0.33 | 5.58 ± 0.39 | 6.22 ± 1.32 | 6.43 ± 1.25 |
 GA (%) | 15.60 ± 4.18 | 16.90 ± 3.41 | 15.84 ± 2.78 | 16.20 ± 3.05 |
 WBC (103/μL) | 6.38 ± 1.65 | 6.01 ± 1.14 | 7.85 ± 1.84 | 7.43 ± 1.45 |
 Hb (g/dL) | 9.80 ± 1.08 | 10.40 ± 0.87 | 10.12 ± 0.87 | 11.08 ± 0.70* |
 CRP (mg/dL) | 0.14 ± 0.13 | 0.37 ± 0.63 | 0.52 ± 0.90 | 0.35 ± 0.46 |